CLINICAL ROLE -
‘Buckybombs' Take Aim at Cancer Cells
Nanoscale treatment could potentially eliminate cancer cells without harming surrounding tissue.
Read More
Patient Death Reported from Mix of Heart Treatment with Blockbuster Hepatitis C Drugs
Co-administration of amiodarone and Sovaldi or Harvoni also causes 9 patients to develop abnormally slow heartbeats, 3 requiring pacemakers.
Live Donor Liver Transplants Found to be Safe, Effective
Procedure allows acute liver failure patients to receive a transplant before their condition worsens.
Nanotechnology May Improve Prostate Cancer Screening
Emerging technology could help patients make better decisions regarding whether to undergo aggressive prostate cancer treatment.
In Case You Missed It: Specialty Pharmacy Times Week in Review
A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.
Periodontitis May Trigger Rheumatoid Arthritis
Condition shares pathogenic mechanisms with rheumatoid arthritis.
Antisense Technology Shows Promising Results in Crohn's Disease Treatment
Significant number of patients taking once daily oral therapy achieve clinical remission during a recent trial.
How Does Melanoma Become Resistant to Targeted Therapy?
Discovery may lead to new treatment designs.
Antibody Therapy Shows Promise in Halting Psoriasis
Experimental treatment blocks signaling protein.
DNA Variations Dictate Preventive Effect of Aspirin on Colorectal Cancer
Genetic variations on chromosome 15 dictate impact of NSAIDs.
Gene Therapy Could Generate Powerful Hemophilia Treatment
Process produces protein with high blood clotting ability.
Preventing Early Menopause in Breast Cancer Patients
Risk of sudden onset menopause reduced by adding goserelin to chemotherapy regimen.
New Approach Needed to Finance Expensive Specialty Drugs
Report finds suppliers could spur investment through methods that include equipment leases or supplier-financed credit.
Nanoparticles May Increase Effectiveness of Lung Cancer Drugs
Treatment can selectively drop medication at the site of tumors.
Harvoni Provides Added Benefit for Certain Hepatitis C Patient Groups
Historical comparison shows advantage in virologic response for patients with genotype 1 hepatitis C.
Risk of Thyroid Cancer Increases After Breast Cancer Diagnosis
Survivors of breast cancer more likely to develop aggressive form of thyroid cancer.
Adjuvant Systemic Therapy for Gastrointestinal Tumors Improves Survival
Study finds older patients and minorities less likely to receive treatment.
A Single Drug Solution for Treatment, Prevention of HIV?
Scientists seek to create powerful defense system that will both attack the virus and prevent infection.
Managing Depression in Cancer Patients
Study finds depression in African American cancer patients has gone under-recognized.